Northwestern Now company blog
New Covid nasal spray outperforms current antibody treatments in mice
A new protein-based antiviral nasal spray is being advanced to Phase I human clinical trials to treat COVID-19. It works by blocking the spike protein's ability to infect cells.
- Points
- 181
- HN comments
- 64
- Submissions
- 1
- Cited by
- 0 commenters
On Hacker News
| Submitted | Title on HN | Points | Comments |
|---|---|---|---|
| Apr 14, 2022 | New Covid nasal spray outperforms current antibody treatments in mice by geox | 181 | 64 |